The new variants might have no competitive edge over the already dominant “Kent variant”.
This could explain their apparently slow spread and could mean that by a grim twist of fate our more transmissible strain that’s caused us such a massive increase in hospitalisations and deaths, might actually be helping to keep these new variants at bay.
The other reason to be cheerful is that the vaccines being deployed have a good chance of preventing severe disease and death from these new variants.
So, even if they were to rise in numbers, the progress we’ve made in vaccination so far is likely to reduce their impact.
And new vaccines, already under development should be available by autumn which as the virus continues to evolve, is when we’ll likely need them ahead of next winter.